glutathione switch persister cells Cancer drug-tolerant cells: from biological questions to clinical opportunities Low-GPX4 drives a sustained drug-tolerant
Low GPX4 drives a sustained drug tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation ScienceDirect Targeting of vulnerabilities of drug tolerant persisters identified through functional genetics delays tumor relapse: Cell Reports Medicine Tolerant Persister Cancer Cells and the Path to Resistance to Targeted Therapy Sustained dysregulation of iron and glutathione homeostasis induces chronoferroptosis, a persistent ferroptotic adaptation in neuronal cells Cell Death Discovery Persister cells have a disabled antioxidant program and depend on GPX4 Download Scientific Diagram Frontiers Drug tolerant persister cells in acute myeloid leukemia: pressing challenge and promising new strategies for treatment
Pay in 4 interest-free payments of $5.02 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6





